Deep Track Capital, LP: holdings and changes

Number 30 of the top 100 funds by copy return. Deep Track Capital, LP reported 71 US stocks worth $5.9B for the quarter ending 2026-09-30 and changed 18 new, 17 added, 16 trimmed and 13 sold since 2026-06-30.

Copy return, 4 quarters+55.6%
US 500, same time+14.5%
Size$5.9B
Stocks71

Holdings

StockChangeWeightValueShares
GH
Guardant Health INC
TRIM -17%8.42%$500M2,805,677
BMRN
Biomarin Pharmaceutical INC
ADD +93%6.44%$382M6,374,395
IMVT
Immunovant INC
5.21%$310M9,160,801
TARS
Tarsus Pharmaceuticals INC
ADD +4%5.04%$299M3,806,768
MANE
Veradermics INC
TRIM -5%3.88%$230M1,900,000
VERA
Vera Therapeutics INC
ADD +75%3.80%$226M7,000,000
PCVX
Vaxcyte INC
TRIM -18%3.36%$200M3,513,069
ALKS
Alkermes PLC
ADD +12%3.07%$182M4,500,000
OCUL
Ocular Therapeutix INC
ADD +11%2.83%$168M21,939,625
UTHR
United Therapeutics Corp
ADD +143%2.74%$163M300,040
GPCR
Structure Therapeutics INC
ADD +5%2.63%$156M5,000,000
GRAL
Grail INC
TRIM -40%2.60%$155M1,104,200
INSM
Insmed INC.
BUY2.59%$154M1,350,000
CMPS
Compass Pathways PLC
2.55%$151M12,161,496
GMAB
Genmab A/S Sp Adr
TRIM -26%2.51%$149M4,182,689
AXSM
Axsome Therapeutics INC
ADD +14%2.48%$148M800,000
NRIX
Nurix Therapeutics INC
TRIM -22%2.39%$142M6,000,000
LBRX
Lb Pharmaceuticals INC
2.17%$129M3,352,804
TNGX
Tango Therapeutics INC
ADD +7%1.89%$112M4,500,000
MAZE
Maze Therapeutics
ADD +9%1.87%$111M4,083,969
COAG
Hemab Therapeutics Hldgs INC
1.86%$111M3,587,796
MLTX
Moonlake Immunot
ADD +16%1.60%$95M8,105,290
ORKA
Oruka Therapeutics INC
TRIM -44%1.50%$89M1,069,774
WGS
Genedx Holdings
ADD +71%1.46%$87M1,200,000
COGT
Cogent Biosciences INC
ADD +25%1.35%$80M2,500,000
GHRS
Gh Research PLC
1.32%$78M3,333,334
BCAX
Bicara Thera INC
1.28%$76M4,100,000
LTGO
Latigo Biotherapeutics INC
BUY1.24%$74M4,408,322
CLDX
Celldex Therapeutics INC
TRIM -28%1.16%$69M2,125,532
BBIO
Bridgebio Pharma INC
BUY0.98%$58M885,882
AVTX
Avalo Therapeutics INC
0.93%$55M3,610,000
ALMS
Alumis INC
ADD +18%0.93%$55M7,469,746
ALT
Altimmune INC
0.93%$55M19,250,000
ATTO
Attovia Therapeutics INC
BUY0.93%$55M3,207,138
BLLN
Billiontoone INC
BUY0.90%$53M500,000
ACRS
Aclaris Therapeutics INC
0.83%$49M9,345,000
CRMD
Cormedix INC
0.81%$48M6,274,076
EWTX
Edgewise Therapeutics INC
BUY0.78%$47M1,148,817
VSTM
Verastem INC
0.78%$46M5,740,850
DFTX
Definium Therapeutics INC
TRIM -64%0.64%$38M1,000,000
GENB
Generate Biomedicines INC
ADD +88%0.63%$38M2,507,449
MBX
Mbx Biosciences INC
TRIM -63%0.63%$38M640,000
BIOSANTE PHARM
Biosante Pharmaceuticals INC
BUY0.61%$36M500,000
VRDN
Viridian Therapeutics INC
TRIM -52%0.59%$35M1,711,030
IMPRIMIS PHARM
Imprimis Pharmaceuticals, INC.
ADD +10%0.55%$33M1,069,000
OBX
Obsidian Therapeutics INC
BUY0.49%$29M2,120,050
CRVS
Corvus Pharmaceuticals INC
0.48%$29M2,491,939
NBIX
Neurocrine Biosciences INC
BUY0.48%$28M200,000
SLDB
Solid Biosciences INC
0.43%$26M3,565,062
STTK
Shattuck Labs INC
0.43%$25M3,706,734
BEAM
Beam Therapeutics INC
0.41%$24M1,000,000
MNKD
Mannkind Corp
TRIM -16%0.33%$20M5,030,522
XENE
Xenon Pharmaceuticals INC
BUY0.31%$19M500,000
OLEMA PHARMACE
Olema Pharmaceut
ADD +41%0.31%$18M2,109,951
NKTR
Nektar Therapeutics
0.31%$18M300,000
DSGN
Design Therapeutics INC
BUY0.28%$17M1,323,986
IPSC
Century Therapeutics INC
0.27%$16M9,462,645
XNCR
Xencor INC
TRIM -9%0.23%$14M540,000
MPLT
Maplight Therapeutics INC
BUY0.23%$13M1,318,101
ENTA
Enanta Pharmaceuticals INC
TRIM -31%0.22%$13M1,000,000
XFOR
X4 Pharmaceuticals INC Com New
TRIM -23%0.22%$13M4,501,684
KARD
Kardigan INC
0.15%$9M600,000
PMN
Promis Neurosciences INC
TRIM -11%0.14%$8M740,117
ENTX
Entera Bio LTD
BUY0.12%$7M2,450,980
RXST
Rxsight INC
BUY0.10%$6M1,230,566
RNAQ
Rainier Acquisition Corp
BUY0.09%$5M500,000
JTTT
Jatt III Acquisition Corp
BUY0.08%$5M450,000
RACD
Research Alliance Corp Iv
BUY0.08%$5M400,000
TCGX
Tcgx Acquisition Corp
BUY0.06%$4M300,000
ALGS
Aligos Therapeutics, INC.
0.04%$2M444,110
CNTX
Context Therapeutics INC
0.04%$2M7,419,355
ALNY
Alnylam Pharmaceuticals INC
SELL0%was $248M0
NUVALENT INC
Nuvalent INC
SELL0%was $220M0
IONS
Ionis Pharmaceuticals INC
SELL0%was $174M0
ATAI BECKLEY N
Atai Beckley Nv
SELL0%was $76M0
CYTK
Cytokinetics INC.
SELL0%was $60M0
PSNL
Personalis INC
SELL0%was $54M0
DYN
Dyne Therapeutics INC
SELL0%was $33M0
IMMX
Immix Biopharma INC
SELL0%was $29M0
KURA
Kura Oncology INC
SELL0%was $22M0
KLRA
Kailera Therapeutics INC
SELL0%was $15M0
ELVN
Enliven Therapeutics INC
SELL0%was $11M0
IMCR
Immunocore Holdings Limited
SELL0%was $10M0
IVA
Inventiva Sa
SELL0%was $3M0

Copy return each quarter

HeldFund copyUS 500
2023-09-30 → 2023-12-31+12.9%+11.2%
2023-12-31 → 2024-03-31+0.2%+10.0%
2024-03-31 → 2024-06-30-0.9%+4.0%
2024-06-30 → 2024-09-30+9.0%+5.4%
2024-09-30 → 2024-12-31-9.1%+2.1%
2024-12-31 → 2025-03-31-12.7%-4.6%
2025-03-31 → 2025-06-30+4.6%+10.5%
2025-06-30 → 2025-09-30+30.6%+7.8%
2025-09-30 → 2025-12-31+37.5%+2.4%
2025-12-31 → 2026-03-31-0.5%-4.6%
2026-03-31 → 2026-06-30+24.0%+14.8%
2026-06-30 → 2026-09-30-8.3%+2.1%

The copy return buys the fund's reported stocks on the day after the filing became public and holds them for one quarter, so it measures what anyone reading the filings could have done.

All top 100 funds, live

Other top funds

Nextech Invest LTD.Venrock Adviser, LLCFairmount Funds Management LLCTalos Eurisko Asset Management LPAnalog Century Management LPQvt Financial LPBroad Peak Investment Advisers Pte LTDWs Management LllpBvf INC/IlParadigm Biocapital Advisors LPOak Grove Capital LLCCm Wealth Advisors LLCAvidity Partners Management LPFirst Light Asset Management, LLCLogos Global Management LPSummit Street Capital Management, LLCMadison Avenue Partners, LPDivisar Capital Management LLCTcg Crossover Management, LLCOptimus Prime Fund Management Co., LTD.Value Aligned Research Advisors, LLCBraidwell LPRedmile Group, LLCOrbimed Advisors LLCMpm Bioimpact LLCCloudalpha Capital Management Limited/Hong KongGeneral Pension Society Pzu Joint Stock CoAmanah Holdings TrustSlate Path Capital LP